Latest Partnerships News

Harvest Technology Group reported improved EBITDA and secured new customers across mining, defence, and border control sectors in Q1 FY2026, supported by $2.13 million raised through convertible notes and loans.

Nelson Resources confirms high-grade gold assay results at its Yarri Project and partners with MEGA Resources to fully fund and manage development operations.

Elixir Energy is set to resume production testing at its Diona-1 well this quarter and prepare for the high-impact Lorelle-3 appraisal well drilling in January 2026, aiming to unlock significant gas resources in Queensland’s Taroom Trough.

Scorpion Minerals Limited has resumed trading following a pivotal announcement on drilling results, a new tenement application, and a potential strategic partnership, alongside financing updates.

Scorpion Minerals reports promising shallow gold intercepts at its Pharos Project and announces a strategic collaboration with Gylden Resources, enhancing processing options in Western Australia’s Murchison region.

Ioneer Ltd has enhanced the economics of its Rhyolite Ridge Lithium-Boron Project by cutting leach retention time, boosting lithium and boron production and improving key financial metrics with minimal capital cost increase.

Associate Global Partners Limited reported a 4.6% increase in funds under management to $1.464 billion for Q3 2025, driven by robust inflows and standout returns from its WCM strategies. The company also sustained positive operating cash flows for the fourth consecutive quarter.

Eclipse Metals has advanced its Greenland rare earths project with expanded drilling and a key licence renewal, while preparing for a NASDAQ dual listing to tap North American investors.

Atomo Diagnostics reported strong commercial momentum in Q1 FY26, highlighted by a key FDA submission for its FebriDx test and a successful capital raise of $1.3 million. The company also showcased promising clinical data for its Active Syphilis test and expanded its HIV Self-Test distribution channels.

CVC Limited is contemplating a fresh offer of Capital Notes, potentially including a reinvestment option for existing holders, contingent on market and regulatory conditions.

Neurizon Therapeutics has secured FDA clearance to resume clinical trials for its lead ALS drug NUZ-001, alongside a $5.2 million capital raise and a key licensing deal with Elanco Animal Health. These developments position the company for a critical growth phase in neurodegenerative disease therapeutics.

FIN Resources Limited has executed a binding agreement to acquire the fully permitted, high-grade Cabin Lake Gold Project in Canada’s Northwest Territories, setting the stage for immediate exploration and resource growth.